Suppr超能文献

[在眼科实践中使用美替洛尔滴眼液进行特殊类型青光眼眼压调节的试验]

[Trials in pressure regulation with metipranolol eyedrops in special forms of glaucoma in ophthalmologic practice].

作者信息

Demmler N

出版信息

Klin Monbl Augenheilkd. 1983 Feb;182(2):153-5. doi: 10.1055/s-2008-1054735.

Abstract

This paper presents the results of a study on the effect of Metipranolol eye drops (Betamann) in 10 patients. The drops were tested with the following forms of glaucoma: glaucoma associated with alpha-kia, neovascular glaucoma, exfoliative glaucoma, pigmentary glaucoma, juvenile glaucoma. Some patients required treatment in combination with miotics. Metipranolol eye drops reduced intraocular pressure by about 15 percent for a prolonged period of time. The pressure-lowering effect was maintained during an observation period of twelve months. Visual acuity and visual fields were constant. The drug was tolerated well subjectively by almost all the patients.

摘要

本文介绍了一项关于美替洛尔滴眼液(倍他洛尔)对10例患者疗效的研究结果。该滴眼液针对以下几种青光眼进行了测试:与α-晶状体蛋白相关的青光眼、新生血管性青光眼、剥脱性青光眼、色素性青光眼、青少年性青光眼。部分患者需要联合缩瞳剂进行治疗。美替洛尔滴眼液可使眼压在较长时间内降低约15%。在12个月的观察期内,眼压降低效果持续存在。视力和视野保持稳定。几乎所有患者对该药物的耐受性良好。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验